Various bacteria and microorganisms can enter the body to for a new infection via various mucosal sites. There is a huge amount of vaccines licensed at the moment ...
The global intranasal drug delivery devices market was valued at $1.7 billion in 2023, and is projected to reach $3.8 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.
